ArticleBMC infectious diseases2026
Clinical and epidemiological characteristics of hospitalized children with enterovirus infection: a retrospective study from 2016 to 2025 at Beijing children's hospital.
Article in BMC infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundEnteroviruses (EVs) are important pathogens that cause neurological and systemic infections in children. Currently, only hand, foot, and mouth disease (HFMD) is monitored in China, indicating a lack of systematic surveillance for other EV-related diseases. Additionally, long-term epidemiological data on pediatric EV infections in Beijing are scarce. The aim of this study was to describe the clinical and epidemiological characteristics of children with EV infection in Beijing over a ten-year period.
methodsIn this retrospective study, all hospitalized patients who underwent EV RNA detection using a fluorescence‑based real‑time PCR assay between July 2016 and July 2025 were included. Demographic, clinical, and laboratory information was retrieved from the hospital’s electronic medical record system.
resultsA total of 8,426 patients was included in this study, and 236 cases (2.80%) tested positive for EVs. Notably, males exhibited a higher detection rate (3.14%, 160/4,940) than females (2.18%, 76/3,486). Moreover, children aged 3 to < 6 months (5.26%, 13/247) and those aged 3 to < 7 years (4.51%, 56/1243) had higher detection rates than other age groups. In terms of seasonal patterns, EV infections demonstrated distinct peak in summer and autumn. Among the 205 patients whose clinical information was complete, viral encephalitis (VE) was identified as the most predominant disease (55.12%, 113/205), particularly among children aged 3 to < 6 years (39.82%, 45/113) and those aged 28 days to < 3 months (10.62%, 12/113). This was followed by myocardial injury/myocarditis (23.41%, 48/205), pneumonia (22.93%, 47/205), hepatic dysfunction (14.63%, 30/205), multiple organ dysfunction syndrome (MODS) (8.78%, 18/205), HFMD (7.80%, 16/205), herpangina (3.90%, 8/205), and arrhythmia (3.41%, 7/205). In this study, 98.05% of the patients had a favorable prognosis, with a mortality rate of 1.95% (4/204).
conclusionsDiseases related to EV infection are among the important reasons for hospitalization in children, among which the top three diseases are encephalitis/meningitis, myocarditis/myocardial damage, and pneumonia. EV infection mainly affects infants and young children under 7 years of age, with the peak incidence in summer and autumn seasons. CLINICAL TRIAL NUMBER: Not applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.